Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Study meets generally accepted principles as a study investigating specific pathways of metabolism by excretion of a single metabolite in urine and exhalation of CO2; minor restrictions: qualitative identification of mandelic acid by TLC, less detailed documentation of test methods and test results; study acceptable as weight of evidence study

Data source

Reference
Reference Type:
publication
Title:
Reaction pathways of in vivo stereoselective conversion of ethylbenzene to mandelic acid
Author:
Sullivan HR, Miller WM, McMahon RE
Year:
1976
Bibliographic source:
Xenobiotica 6: 49-54

Materials and methods

Objective of study:
metabolism
Principles of method if other than guideline:
Excretion of mandelic acid analyzed in urine by preparative TLC after cleavage of conjugates; after dosing with 14C-acetophenone (label at methyl carbon) exhalation of 14CO2 was followed
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Acetophenone
EC Number:
202-708-7
EC Name:
Acetophenone
Cas Number:
98-86-2
Molecular formula:
C8H8O
IUPAC Name:
1-phenylethanone
Details on test material:
boiling point: 200-202 degrees C
Radiolabelling:
yes
Remarks:
14C at the methyl group

Test animals

Species:
rat
Strain:
other: Albino
Sex:
male

Administration / exposure

Route of administration:
intraperitoneal
Duration and frequency of treatment / exposure:
single
Doses / concentrations
Remarks:
Doses / Concentrations:
100 mg/kg
No. of animals per sex per dose / concentration:
8
Details on dosing and sampling:
METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled: urine
- Time and frequency of sampling: for 24 hrs
- From how many animals: (samples pooled or not) 8
- Method type(s) for identification: isolation of mandelic acid by preparative thin layer chromatography
- Limits of detection and quantification: not specified

TREATMENT FOR CLEAVAGE OF CONJUGATES
Hydrolysis of conjugates by incubation with aryl sulfatase and ß-glucuronidase

OTHER INVESTIGATIONS
Exhalation of 14CO2 was followed for up to 13 hrs.

Results and discussion

Metabolite characterisation studies

Metabolites identified:
yes
Details on metabolites:
in urine: mandelic acid;
exhalation of 14CO2 accounted to 10 % during first 4 hrs and to 30 % during 13 hrs post application indicating formation of benzoic acid as further metabolite

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): bioaccumulation potential cannot be judged based on study results
Acetophenone is metabolized to mandelic acid and the formation of benzoic acid is indicated by exhalation of CO2.
Executive summary:

In rats, acetophenone is metabolized to mandelic acid after intraperitoneal injection of 14C-methyl labeled acetophenone (100 mg/kg). The formation of benzoic acid is indicated by exhalation of CO2 (10% during the first 4 hrs and 30% during 13 hrs post application).